Repros Therapeutics (RPRX) Tops Q1 EPS by 2c
Tweet
Share
E-mailGet Alerts RPRX Hot Sheet
Price: $56.07 -1.79%
Financial Fact:
Loss per share - basic and diluted:: -0.17
Today's EPS Names:
DTGI, CRMT, STZ, More
Financial Fact:
Loss per share - basic and diluted:: -0.17
Today's EPS Names:
DTGI, CRMT, STZ, More
Join SI Premium – FREE
Repros Therapeutics (NASDAQ: RPRX) reported Q1 EPS of ($0.20), $0.02 better than the analyst estimate of ($0.22).
For earnings history and earnings-related data on Repros Therapeutics (RPRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- NVIDIA stock gains as SemiAnalysis sees H2 data center revenue 20% above consensus
- Nike (NKE) PT Lowered to $60 at Guggenheim
- JPMorgan Reiterates Neutral Rating on Alcoa (AA)
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
